Page last updated: 2024-11-05
2,4,6-tribromoaniline
Description
2,4,6-tribromoaniline is a white to off-white solid with the molecular formula C6H4Br3N. It is a brominated derivative of aniline, where three bromine atoms are substituted at the 2, 4, and 6 positions on the benzene ring. It is a versatile reagent used as a starting material in the synthesis of various organic compounds. Its importance lies in its potential applications in organic synthesis, particularly in the synthesis of pharmaceuticals and agrochemicals. For example, it can be used as a building block for the synthesis of triazole-based fungicides. It is often studied due to its unique structural properties and potential for use in the synthesis of new and useful materials. Research on 2,4,6-tribromoaniline includes exploring its reactivity and investigating its potential as a precursor for new organic materials.'
2,4,6-tribromoaniline: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 8986 |
| SCHEMBL ID | 29210 |
| MeSH ID | M0483381 |
Synonyms (56)
| Synonym |
|---|
| HMS1577N09 |
| einecs 205-700-1 |
| aniline tribromide |
| ai3-21064 |
| nsc 2216 |
| 2,4,6-tribromophenylamine |
| hsdb 2689 |
| sym-tribromoaniline |
| brn 2209258 |
| 2,4,6-tribromobenzenamine |
| (2,4,6-tribromo-phenyl)-amine |
| usaf do-43 |
| wln: zr be de fe |
| nsc2216 |
| 2,6-tribromophenylamine |
| benzenamine,4,6-tribromo- |
| nsc-2216 |
| aniline,4,6-tribromo- |
| 147-82-0 |
| 2,6-tribromoaniline |
| s-tribromoaniline |
| aniline, 2,4,6-tribromo- |
| 2,4,6-tribromoaniline |
| STK084272 |
| benzenamine, 2,4,6-tribromo- |
| inchi=1/c6h4br3n/c7-3-1-4(8)6(10)5(9)2-3/h1-2h,10h |
| 2,4,6-tribromoaniline, 98% |
| AC-10671 |
| AKOS000118846 |
| 52628-37-2 |
| T1088 |
| T0345 |
| A808698 |
| 2,4,6-tris(bromanyl)aniline |
| AE-641/00784057 |
| 4-12-00-01538 (beilstein handbook reference) |
| unii-0c2n8wil3b |
| 0c2n8wil3b , |
| FT-0609838 |
| SCHEMBL29210 |
| 2,4,6-tribromoaniline [mi] |
| DTXSID5051733 |
| W-108111 |
| 2,4,6-tribomoaniline |
| 2,4,6-tribromoanine |
| sr-01000390863 |
| SR-01000390863-1 |
| BR1211 |
| mfcd00007634 |
| tribromanilin |
| Q4029749 |
| EN300-19592 |
| PS-10201 |
| AMY8955 |
| D92327 |
| Z104474384 |
Bioassays (4)
| Assay ID | Title | Year | Journal | Article |
|---|
| AID588519 | A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities | 2011 | Antiviral research, Sep, Volume: 91, Issue:3
| High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors. |
| AID540299 | A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis | 2010 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
| Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. |
| AID1794808 | Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL). | 2014 | Journal of biomolecular screening, Jul, Volume: 19, Issue:6
| A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum. |
| AID1794808 | Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL). | | | |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 63.05
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 63.05 (24.57) | | Research Supply Index | 1.79 (2.92) | | Research Growth Index | 4.51 (4.65) | | Search Engine Demand Index | 96.15 (26.88) | | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |